Calgary Stroke Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Canada (E.E.S.).
Department of Neurology (J.L.S.) and Division of Cardiology (G.C.F.).
Circulation. 2017 Dec 12;136(24):2303-2310. doi: 10.1161/CIRCULATIONAHA.117.031097. Epub 2017 Oct 5.
Beginning in December 2014, a series of pivotal trials showed that endovascular thrombectomy (EVT) was highly effective, prompting calls to reorganize stroke systems of care. However, there are few data on how these trials influenced the frequency of EVT in clinical practice. We used data from the Get With The Guidelines-Stroke program to determine how the frequency of EVT changed in US practice.
We analyzed prospectively collected data from a cohort of 2 437 975 patients with ischemic stroke admitted to 2222 participating hospitals between April 2003 and the third quarter of 2016. Weighted linear regression with 2 linear splines and a knot at January 2015 was used to compare the slope of the change in EVT use before and after the pivotal trials were published. Potentially eligible patients were defined as last known well to arrival time ≤4.5 hours and National Institutes of Health Stroke Scale score ≥6.
The frequency of EVT use was slowly increasing before January 2015 but then sharply accelerated thereafter. In the third quarter 2016, EVT was provided to 3.3% of all patients with ischemic stroke at all hospitals, representing 15.1% of all patients who were potentially eligible for EVT based on stroke duration and severity. At EVT-capable hospitals, 7.5% of all patients with ischemic stroke were treated in the third quarter of 2016, including 27.3% of the potentially eligible patients. From 2013 to 2016, case volumes nearly doubled at EVT-capable hospitals. Mean case volume per EVT-capable hospital was 37.6 per year in the last 4 quarters. EVT case volumes increased in nearly all US states from 2014 to the last 4 quarters, but with persistent geographic variation unexplained by differences in potential patient eligibility.
EVT use is increasing rapidly; however, there are still opportunities to treat more patients. Reorganizing stroke systems to route patients to adequately resourced EVT-capable hospitals might increase treatment of eligible patients, improve outcomes, and reduce disparities.
自 2014 年 12 月以来,一系列关键试验表明血管内血栓切除术(EVT)非常有效,这促使人们呼吁重新组织脑卒中护理系统。然而,关于这些试验如何影响临床实践中 EVT 的频率的数据很少。我们使用来自 Get With The Guidelines-Stroke 计划的数据来确定美国实践中 EVT 的频率如何变化。
我们分析了 2003 年 4 月至 2016 年第三季度期间,在 2222 家参与医院收治的 2437975 例缺血性脑卒中患者前瞻性收集的数据。使用具有 2 个线性样条和 1 个 2015 年 1 月结的加权线性回归来比较关键试验公布前后 EVT 使用变化的斜率。潜在符合条件的患者定义为最后一次知道自己状态良好到到达时间≤4.5 小时和 NIHSS 评分≥6。
在 2015 年 1 月之前,EVT 的使用频率缓慢增加,但此后急剧加速。在 2016 年第三季度,所有医院中 3.3%的缺血性脑卒中患者接受了 EVT,代表基于卒中持续时间和严重程度所有潜在符合 EVT 条件的患者的 15.1%。在有 EVT 能力的医院中,2016 年第三季度 7.5%的缺血性脑卒中患者接受了治疗,其中 27.3%的潜在符合条件的患者。从 2013 年到 2016 年,EVT 能力医院的病例量几乎翻了一番。在过去的 4 个季度中,每个 EVT 能力医院的平均病例量为 37.6 例。从 2014 年到最后 4 个季度,几乎所有美国州的 EVT 病例量都有所增加,但仍存在无法用潜在患者资格差异解释的持续地域差异。
EVT 的使用正在迅速增加;然而,仍有机会治疗更多的患者。重新组织脑卒中系统,将患者转至资源充足的 EVT 能力医院,可能会增加对符合条件的患者的治疗,改善结局并减少差异。